Global Hepatitis A Vaccine Market: Latest Sales Revenue & Market Share by Companies in to 2023
The recently revealed report titled Global Hepatitis A Vaccine Market Industry 2018 Market research Explore is an in depth study providing complete analysis of the industry for the period 2018 – 2023.
(EMAILWIRE.COM, September 05, 2018 ) September 2018, New York USA (News)- In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Hepatitis A Vaccine market for 2018-2023.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
105.3 million USD by 2022 in Asia-Pacific market.
Get Sample Report @ https://www.researchreportsinc.com/sample-request?id=178552
Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.
Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
Over the next five years, LPI(LP Information) projects that Hepatitis A Vaccine will register a 2.8% CAGR in terms of revenue, reach US$ 770 million by 2023, from US$ 650 million in 2017.
Get Customized Report @ https://researchreportsinc.com/enquiry?id=178552
The key manufacturers covered in this report:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac
Segmentation by product type:
Inactivated Vaccine
Live Attenuated Vaccine
Segmentation by application:
Government Institution
Private Sector
Other
Buy Report @ https://researchreportsinc.com/checkout/?add-to-cart=178552&&attribute_pa_choose-license=single-user&&quantity=1
Research objectives
To study and analyze the global Hepatitis A Vaccine (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Floriculture market by identifying its various sub segments.
Focuses on the key global Floriculture manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Floriculture with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Floriculture submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Contact Us:
David
Sales Manager,
US / Canada Toll Free: +18554192424
UK: +4403308087757
Email: sales@researchreportsinc.com
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
Two types of HAV vaccines are currently available internationally:
1. Formaldehyde-inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
105.3 million USD by 2022 in Asia-Pacific market.
Get Sample Report @ https://www.researchreportsinc.com/sample-request?id=178552
Live attenuated vaccines (based on H2 or LA-1 HAV strains): These vaccines are manufactured and used mainly in China and sporadically in the private sector in India.
Hepatitis A vaccine is a vaccine which is against the hepatitis A virus. The Hepatitis A vaccine is available for long-term prevention of HAV infection, Minimum age for HAV vaccination is 1 year.
The classification of Hepatitis A Vaccine includes Inactivated Vaccine, Live Attenuated Vaccine, and the sales proportion of Inactivated Vaccine in 2017 is about 70.8%, and the proportion is increasing trend from 2013 to 2018.
Inactivated vaccines: Inactivated HAV vaccines are used in most countries. Monovalent inactivated HAV vaccines are available in paediatric dose (0.5 ml) for children aged 1 year to 15 years, and in adult dose (1 ml).
Over the next five years, LPI(LP Information) projects that Hepatitis A Vaccine will register a 2.8% CAGR in terms of revenue, reach US$ 770 million by 2023, from US$ 650 million in 2017.
Get Customized Report @ https://researchreportsinc.com/enquiry?id=178552
The key manufacturers covered in this report:
GSK
Merck
Sanofi
Sinovac
Zhejiang Pukang
Changchun Institute of Biological
Kaketsuken
IMBCA
ChangSheng
Convac
Segmentation by product type:
Inactivated Vaccine
Live Attenuated Vaccine
Segmentation by application:
Government Institution
Private Sector
Other
Buy Report @ https://researchreportsinc.com/checkout/?add-to-cart=178552&&attribute_pa_choose-license=single-user&&quantity=1
Research objectives
To study and analyze the global Hepatitis A Vaccine (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
To understand the structure of Floriculture market by identifying its various sub segments.
Focuses on the key global Floriculture manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Floriculture with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Floriculture submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Contact Us:
David
Sales Manager,
US / Canada Toll Free: +18554192424
UK: +4403308087757
Email: sales@researchreportsinc.com
Contact Information:
Research Reports Inc
Shubham Goel
Tel: 8554192424
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Research Reports Inc
Shubham Goel
Tel: 8554192424
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results